Tokyo, July 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058505) titled 'Atopic Dermatitis in Clinical Practice Patient Reported Outcome(PRO)Fact-Finding Study' on July 18.
Study Type:
Observational
Primary Sponsor:
Institute - Otsuka Pharmaceutical Co., Ltd.
Condition:
Condition - Atopic Dermatitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Investigate the actual use of PRO in atopic dermatitis practice
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Physicians who meet all of the following selection criteria will be inclu...